Deflazacort Oral Suspension 22.75 mg/mL
Deflazacort Oral · SUSPENSION · Cranbury Pharmaceuticals, LLC
Deflazacort Oral Suspension is a suspension containing deflazacort oral at 22.75 mg/mL, taken oral. Manufactured by Cranbury Pharmaceuticals, LLC.
Key Facts
- Brand Name
- Deflazacort Oral Suspension
- Generic Name
- Deflazacort Oral
- NDC Code (Product)
27808-249- Manufacturer
- Cranbury Pharmaceuticals, LLC
- Strength
- 22.75 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA217813
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 05/01/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Deflazacort Oral Suspension used for?
Deflazacort Oral Suspension contains Deflazacort Oral. It is a suspension taken oral. Consult your doctor for specific uses.
Is Deflazacort Oral Suspension a controlled substance?
Deflazacort Oral Suspension is not classified as a controlled substance by the DEA.
What is the generic name for Deflazacort Oral Suspension?
The generic name for Deflazacort Oral Suspension is Deflazacort Oral. There are no other listed brand versions of Deflazacort Oral.
What is the NDC code for Deflazacort Oral Suspension 22.75 mg/mL?
The NDC (National Drug Code) for Deflazacort Oral Suspension 22.75 mg/mL is 27808-249, listed by Cranbury Pharmaceuticals, LLC.
Other Deflazacort Oral Suspension Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)